# Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST

> **NCT00979329** · — · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 100 (actual)

## Conditions studied

- Renal Cell Cancer
- Colorectal Cancer
- GIST

## Interventions

- **OTHER:** Questionnaires

## Key facts

- **NCT ID:** NCT00979329
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2011-12
- **Final completion:** 2015-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00979329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00979329, "Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00979329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*